These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 7184365
1. [Compound therapy including PSK for malignant head and neck cancer]. Hoshiya T, Matsunaga T, Hyo Y, Mori N, Kakiuchi H, Saeki K, Wakuda K. Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365 [Abstract] [Full Text] [Related]
2. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group]. Ichihashi H, Kondo T, Nakazato H. Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635 [Abstract] [Full Text] [Related]
3. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection. Kondo T, Sakamoto J, Nakazato H. Biotherapy; 1991 Sep; 3(4):287-95. PubMed ID: 1786194 [Abstract] [Full Text] [Related]
4. Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma. Mickey DD. Cancer Chemother Pharmacol; 1985 Sep; 15(1):54-8. PubMed ID: 4006049 [Abstract] [Full Text] [Related]
6. [The effect of PSK on laryngeal cancer]. Saito H, Hozawa J, Kamata S, Hakamada M, Kasahara M, Takagi A. Gan To Kagaku Ryoho; 1982 Jul; 9(6):1061-7. PubMed ID: 7184440 [Abstract] [Full Text] [Related]
8. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group]. Nakazato H, Ichihashi H, Kondo T. Gan To Kagaku Ryoho; 1986 Feb; 13(2):308-18. PubMed ID: 3947108 [Abstract] [Full Text] [Related]
9. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. Yokoe T, Iino Y, Takei H, Horiguchi J, Koibuchi Y, Maemura M, Ohwada S, Morishita Y. Anticancer Res; 1997 Feb; 17(4A):2815-8. PubMed ID: 9252721 [Abstract] [Full Text] [Related]
10. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, Amano T, Takahashi T, Murayama N, Oka H. Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313 [Abstract] [Full Text] [Related]
11. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Fisher M, Yang LX. Anticancer Res; 2002 Feb; 22(3):1737-54. PubMed ID: 12168863 [Abstract] [Full Text] [Related]
12. PSK immunotherapy in cancer patients--a preliminary report. Chung CH, Go P, Chang KH. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):210-6. PubMed ID: 3322700 [Abstract] [Full Text] [Related]
13. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. Kudo S, Tanaka J, Kashida H, Tamegai Y, Endo S, Yamano HO. Oncol Rep; 2002 Aug; 9(3):635-8. PubMed ID: 11956642 [Abstract] [Full Text] [Related]
14. Adjuvant PSK immunotherapy in patients with carcinoma of the nasopharynx. Go P, Chung CH. J Int Med Res; 1989 Aug; 17(2):141-9. PubMed ID: 2656331 [Abstract] [Full Text] [Related]
15. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer. Sugimachi K, Maehara Y, Kusumoto T, Okamura T, Korenaga D, Kohnoe S, Baba H, Anai H. Anticancer Res; 1995 Aug; 15(5B):2175-9. PubMed ID: 8572620 [Abstract] [Full Text] [Related]
16. [The effect of immunochemotherapy with PSK in malignant tumors of the female reproductive organs]. Fujisawa S, Suzumori K, Yasui Y, Yamamoto T, Yagami Y. Gan No Rinsho; 1986 Jan; 32(1):65-70. PubMed ID: 3485203 [Abstract] [Full Text] [Related]
17. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer. Nio Y, Tsubono M, Tseng CC, Morimoto H, Kawabata K, Masai Y, Shiraishi T, Imai S, Ohgaki K, Tobe T. Biotherapy; 1992 Jan; 4(2):117-28. PubMed ID: 1622733 [Abstract] [Full Text] [Related]
18. [Evaluation of a combined application of radiotherapy, carboquone, and PSK in malignant tumor--clinical results at 7 facilities]. Tsuya A, Kaneda K, Mikuriya S, Horiuchi J, Amino S, Mochizuki S, Kamata R, Ikeda M, Okawa T. Gan No Rinsho; 1982 Jan; 28(1):49-54. PubMed ID: 7182548 [No Abstract] [Full Text] [Related]
19. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Yefenof E, Gafanovitch I, Oron E, Bar M, Klein E. Cancer Immunol Immunother; 1995 Dec; 41(6):389-96. PubMed ID: 8635197 [Abstract] [Full Text] [Related]
20. Adjuvant chemoimmunotherapy in advanced lesions of the head and neck. Eilber FR, Morton DL. AJR Am J Roentgenol; 1976 May; 126(5):1082-7. PubMed ID: 178233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]